Great West Life Assurance CO Xenon Pharmaceuticals Inc. Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 15,911 shares of XENE stock, worth $598,571. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,911
Previous 15,911
-0.0%
Holding current value
$598,571
Previous $628,000
0.8%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
66.7MCall Options Held
109KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$213 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$170 Million1.73% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$110 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$108 Million0.06% of portfolio
-
Commodore Capital LP New York, NY2.74MShares$103 Million10.76% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.34B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...